title: [Effect of knocking down eEF1A1 gene on proliferation and apoptosis in Jurkat cells and its mechanisms].
abstract: This study was purposed to investigate the effect of knocking down eukaryotic elongation factor 1A1 (eEF1A1) gene on the proliferation and apoptosis in human acute T lymphocytic leukemia (T-ALL) cell line Jurkat and explore its mechanism. The eEF1A1 mRNA and protein expressions of Jurkat cells and 3 healthy adult peripheral blood mononuclear cells (PBMNC) were detected by real time PCR and Western blot, respectively. eEF1A1-shRNA lentivirus was constructed through molecular biological method, and was used to transfect Jurkat cells. Then, cell eEF1A1 mRNA and protein expressions were detected by real time PCR and Western blot, respectively. Cell proliferation, apoptosis and cycle were detected by MTT method, Annexin V-APC labeling and DNA ploidy analysis, respectively. Cell-related protein expressions of phosphatidylinositol-3-kinase (PI3K)/serine/threonine kinase (Akt) signaling pathway were detected by Western blot. The results showed that eEF1A1 mRNA and protein expression levels of Jurkat cells were significantly higher than that of healthy adult PBMNC, respectively (P < 0.01, P < 0.05). eEF1A1 mRNA and protein expressions of Jurkat cells were significantly knocked down by constructing eEF1A1-shRNA lentivirus. Compared to negative control group (transfected with negative control-shRNA lentivirus), cell proliferation in eEF1A1-shRNA group was significantly inhibited, cell apoptosis was remarkably induced, cell cycle was blocked in G(0)/G(1) phase, and the expression levels of p-Akt (Ser 473), nuclear factor kappa B (NF-κB), p-NF-κB (Ser 468), mammalian target of rapamycin (mTOR) and p-mTOR (Ser 2448) proteins were significantly reduced. It is concluded that eEF1A1 may be a putative oncoprotein in T-ALL cells. Knocking down eEF1A1 gene has noticeable effects on the proliferation inhibition and apoptosis induction of Jurkat cells, which may be mediated by the down-regulation of PI3K/Akt/NF-κB and PI3K/Akt/mTOR signaling pathway.
authors.affiliation: Department of Clinical Laboratory, Provincial Clinical College, Fujian Medical University, Fujian Province, China. Hyi8070@126.com
authors.forename: Yi
authors.initials: Y
authors.lastname: Huang
authors.forename: Jian-Da
authors.initials: JD
authors.lastname: Hu
authors.forename: Yuan-Lin
authors.initials: YL
authors.lastname: Qi
authors.forename: Yan-An
authors.initials: YA
authors.lastname: Wu
authors.forename: Jing
authors.initials: J
authors.lastname: Zheng
authors.forename: Ying-Yu
authors.initials: YY
authors.lastname: Chen
authors.forename: Xiao-Li
authors.initials: XL
authors.lastname: Huang
mesh_terms: D017209:Apoptosis; D049109:Cell Proliferation; D020868:Gene Silencing; D006801:Humans; D019169:Jurkat Cells; D020648:Peptide Elongation Factor 1 / Q000235:genetics*; D019869:Phosphatidylinositol 3-Kinases / Q000378:metabolism; D051057:Proto-Oncogene Proteins c-akt / Q000378:metabolism; D015398:Signal Transduction / Q000235:genetics
chemical_list: C094814:EEF1A1 protein, human; D020648:Peptide Elongation Factor 1; D019869:Phosphatidylinositol 3-Kinases; D051057:Proto-Oncogene Proteins c-akt